MS Supplements: What Works and What Doesn’t

In an interview with Pharmacy Times at the Consortium of Multiple Sclerosis Centers 2026, Julie Kidd, PhD, MPH, BCPS, the director of clinical services at Blue Ridge Neurology, presenting on Supplements in Multiple Sclerosis, discussed what works and what doesn't in MS supplements.

Kidd discussed the growing interest in supplements among patients with multiple sclerosis (MS), particularly as patients look for ways to manage symptoms such as fatigue or support overall health. The conversation focused on how patients are increasingly exposed to information about supplements and alternative therapies through social media and online wellness trends.

During the interview, Kidd addressed the challenge of balancing patient interest in “natural” therapies with the need for evidence-based care. The discussion explored which supplements currently have stronger scientific support in MS care and which therapies may be receiving more attention than the evidence currently supports. Vitamin D was highlighted as one of the most commonly discussed supplements in MS, including how clinician perspectives and recommendations have evolved alongside emerging research.

Kidd also spoke about the influence of social media on supplement use in the MS community. The interview examined concerns surrounding misinformation, exaggerated claims, and the potential risks of patients relying on unsupported therapies without guidance from health care professionals. The discussion emphasized the importance of helping patients evaluate supplement information carefully and encouraging open conversations between patients and clinicians about safety, expectations, and evidence.

Overall, the interview highlighted the ongoing interest in supplements and alternative therapies in MS care, while underscoring the importance of grounding treatment discussions in available scientific evidence and clinical judgment.